
Shivani Bhadresh Desai
About Shivani Bhadresh Desai
Data last updated:
Shivani Bhadresh Desai is a Director at R-Biopharm Neugen Private Limited (since 2021), Whole-Time Director at Chromogenic Life Sciences (India) Private Limited (since 2020) and Director at Trilogy Analytical Laboratory Private Limited (since 2021). The companies operate in Healthcare and Life Sciences. The 3 current companies with reported revenue have a combined latest revenue of ₹27.38 Cr; the largest is R-Biopharm Neugen Private Limited at ₹21.72 Cr (FY 2024). Earlier, Shivani Bhadresh Desai was a Director at Sd Hygiclean Private Limited (from 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Mar 2021 | 1997 | ₹21.72 Cr (FY 2024) | Active | |
| Whole-Time Director | 13 Jan 2020 | 2011 | ₹3.91 Cr (FY 2024) | Active | |
| Director | 05 Apr 2021 | 2015 | ₹1.75 Cr (FY 2021) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Mar 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shivani Bhadresh Desai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Christian Moraeno Dreher | 06720942 | R-Biopharm Neugen Private Limited | Director |
| Rabindra Chakraborty | 09153142 | Chromogenic Life Sciences (India) Private Limited , Trilogy Analytical Laboratory Private Limited | Whole-Time Director |
| Ryan James Malone | 07494333 | Trilogy Analytical Laboratory Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shivani Bhadresh Desai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shivani Bhadresh Desai
Shivani Bhadresh Desai currently holds 3 directorships: R-Biopharm Neugen Private Limited (Director, since 04 Mar 2021, revenue ₹21.72 Cr (FY 2024)); Chromogenic Life Sciences (India) Private Limited (Whole-Time Director, since 13 Jan 2020, revenue ₹3.91 Cr (FY 2024)); Trilogy Analytical Laboratory Private Limited (Director, since 05 Apr 2021, revenue ₹1.75 Cr (FY 2021)).
Shivani Bhadresh Desai was first appointed on 17 Mar 2017 as Director at Sd Hygiclean Private Limited. The most recent appointment on record is 05 Apr 2021 at Trilogy Analytical Laboratory Private Limited.
The 3 current companies of Shivani Bhadresh Desai that report revenue have a combined latest revenue of ₹27.38 Cr: R-Biopharm Neugen Private Limited ₹21.72 Cr (FY 2024); Chromogenic Life Sciences (India) Private Limited ₹3.91 Cr (FY 2024); Trilogy Analytical Laboratory Private Limited ₹1.75 Cr (FY 2021).
Shivani Bhadresh Desai held 1 earlier board appointment: Sd Hygiclean Private Limited (Director, from 17 Mar 2017).
The current boards of Shivani Bhadresh Desai's companies include Christian Moraeno Dreher (R-Biopharm Neugen Private Limited), Rabindra Chakraborty (Chromogenic Life Sciences (India) Private Limited), Ryan James Malone (Trilogy Analytical Laboratory Private Limited).